phosphatidylcholines has been researched along with norcantharidin in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (norcantharidin) | Trials (norcantharidin) | Recent Studies (post-2010) (norcantharidin) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 272 | 0 | 188 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | norcantharidin (IC50) |
|---|---|---|---|
| PPP5C protein, partial | Homo sapiens (human) | 2.567 | |
| serine/threonine-protein phosphatase PP1-alpha catalytic subunit isoform 3 | Homo sapiens (human) | 2.832 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawei, C; Haibing, H; Lixin, W; Ruiying, S; Xing, T | 1 |
1 other study(ies) available for phosphatidylcholines and norcantharidin
| Article | Year |
|---|---|
A less irritant norcantharidin lipid microspheres: formulation and drug distribution.
Topics: alpha-Tocopherol; Animals; Bridged Bicyclo Compounds, Heterocyclic; Chemistry, Pharmaceutical; Enzyme Inhibitors; Glycerol; Hydrogen-Ion Concentration; Infusions, Intravenous; Injections, Intramuscular; Lipids; Microspheres; Molecular Structure; Oleic Acid; Particle Size; Phosphatidylcholines; Polysorbates; Rabbits; Rats; Rats, Wistar; Solvents | 2006 |